Trial Profile
Impact of Dapagliflozin on DIAstolic Dysfunction in Type 2 Diabetic Patients: The IDDIA Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IDDIA
- 13 Jul 2020 Status changed from active, no longer recruiting to completed.
- 10 Dec 2019 Status changed from recruiting to active, no longer recruiting.
- 10 Dec 2019 Planned End Date changed from 1 Jul 2019 to 1 Jan 2020.